Study to Evaluate the Efficacy of Elix's Cycle Balance and Its Impact on PMS and Menstrual Symptoms
Launched by ZENCHI, INC. · Nov 23, 2021
Trial Information
Current as of August 11, 2025
Completed
Keywords
ClinConnect Summary
No description provided
Gender
FEMALE
Eligibility criteria
- Inclusion Criteria:
- • Female aged 18-36
- • Self-reported moderate to severe discomfort during menstruation, related to pelvic cramps, bloating, mood swings, or fatigue
- • May experience regular or irregular menstrual cycle
- • May be on birth control
- • Must know or can estimate the date of the next cycle/period
- • May find blood clots in menstrual blood
- • Must be in good health (doesn't report any medical conditions asked in the screening questionnaire)
- • Following a stable, consistent diet regimen
- • Follow a stable, consistent exercise regimen and are willing, for the duration of the study, to not decrease or increase the amount of exercise in their regimen
- • Agree to refrain from any lifestyle changes that may affect their menstrual cycle for the duration of the study (for example, getting on or off hormonal birth control, reducing the amount of exercise)
- • Follow a stable consistent regimen when using any other interventions, such as massage, chiropractic medicine, or acupuncture; agree not to increase or decrease the number of their other interventions
- • Willingness to adhere to the dietary supplement regimen
- • Willingness to refrain from any other dietary supplements targeting the menstrual cycle during the study period
- • Is able to communicate in English
- • Is willing and able to share feedback via the used technology portal
- • Must provide written informed consent (ICF)
- Exclusion Criteria:
- • Don't experience a menstrual cycle
- • Can't estimate the onset of their next menstrual cycle
- • Don't experience menstrual cramping
- • Follow an extreme diet intervention
- • Experienced severe weight loss in the past 3 months prior to study participation
- • Usage of any medication or herbal remedies/supplements which can affect the menstrual cycle
- • If currently taking allowed supplements, the dosage needs to remain the same throughout the entirety of the study
- • Food intolerances/allergies that require an EpiPen
- • Known allergic reaction to any of the test product ingredients
- • Currently pregnant, want to become pregnant for the duration of the study, or who are breastfeeding
- • Previous users of Elix Cycle Balance
- • Having more than 3 alcoholic drinks a day
- • Have been diagnosed with the following conditions: PCOS, Endometriosis, PMDD, Adenomyosis, Hashimoto's, anorexia, bulimia, orthorexia, binge eating, any other eating disorder
- • Smokers
- • Not been on a stable dose of birth control for the past 6 months
About Zenchi, Inc.
Zenchi, Inc. is a clinical trial sponsor dedicated to advancing innovative therapeutic solutions through rigorous research and development in the healthcare sector. Committed to improving patient outcomes, Zenchi specializes in the design, management, and execution of clinical trials across various therapeutic areas. With a focus on collaboration and ethical practices, the company leverages cutting-edge technology and a highly skilled team to ensure the highest standards of scientific integrity and compliance. Zenchi, Inc. strives to bridge the gap between groundbreaking research and effective treatment options, ultimately enhancing the quality of care for patients worldwide.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Santa Monica, California, United States
Patients applied
Trial Officials
Susanne Mitschke, MSc
Principal Investigator
Citruslabs
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials